Cell Source, Inc. SEC filings CLCS

Cell Source, Inc. has 139 filings in SEC EDGAR's recent list, going back to Mar 5, 2013. Its latest annual report, Form 10-K, was filed on Apr 7, 2026 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Jun 27, 2025 (auditor change). The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Nov 12, 2014 —
S-1/A Amended registration statement Oct 24, 2014 —
S-1/A Amended registration statement Sep 23, 2014 —
S-1 Registration statement Aug 8, 2014 —
424B2 Prospectus Sep 18, 2013 —
S-1/A Amended registration statement Sep 6, 2013 —
S-1/A Amended registration statement Aug 20, 2013 —
S-1/A Amended registration statement Aug 6, 2013 —
S-1/A Amended registration statement Jul 15, 2013 —
S-1/A Amended registration statement Jun 10, 2013 —
S-1/A Amended registration statement May 10, 2013 —
S-1 Registration statement Mar 5, 2013 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLCS (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1569340
Former names
TICKET TO SEE, INC. (until Jun 26, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.